Michelle Ross, Stempoint Capital CIO, joins ‘Closing Bell’ to talk her perspective on the Biotech sector, companies she is watching in the space, and more.
StemPoint Capital | ‘Closing Bell’
The JCP Platform experienced a second consecutive year of record investment activity across high-quality opportunities.
Michelle Ross, StemPoint Capital CIO, joins ‘Closing Bell’ to discuss the small and mid-cap biotech stocks, the patent cliff coming for the companies in the sector and much more.
Click to see a collection of charts pertaining to the digital assets landscape.